Giant cell arteritis (GCA) is the commonest of the large-vessel vasculitides. Aortic inflammation in patients with GCA was first described over 80 years ago, but it has only been possible to study this systematically following the development of more sophisticated imaging techniques such as computed tomography angiography, magnetic resonance angiography and positron emission tomography. Both NICE and the European League Against Rheumatism (EULAR) recognise that aortic dissection may complicate GCA but stop short of recommending routine imaging. We report a case that highlights a possible need for large-vessel imaging at the time of diagnosis and during follow-up to enable earlier recognition of aortitis and associated complications including dissection.
LiKJSemenovDTurkMet al. A meta-analysis of the epidemiology of giant cell arteritis across time and space. Arthritis Res Ther2021; 23: 82.
2.
González-GayMÁOrtego-JuradoMErcoleLet al. Giant cell arteritis: is the clinical spectrum of the disease changing?BMC Geriatr2019; 19: 1–7.
3.
EvansJMO’FallonWMHunderGG.Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis: a population-based study. Ann Intern Med1995; 122: 502–7.
4.
de BoyssonHEspitiaOSamsonMet al. Giant cell arteritis-related aortic dissection: a multicenter retrospective study. Semin Arthritis Rheum2021; 51: 430–5.
5.
NuenninghoffDMHunderGGChristiansonTJet al. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum2003; 48: 3522–31.
6.
Gonzalez-GayMAGarcia-PorruaCPiñeiroAet al. Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain: a population-based study. Medicine (Baltimore)2004; 83: 335–41.
7.
García-MartínezAHernández-RodríguezJArguisPet al. Development of aortic aneurysm/dilatation during the followup of patients with giant cell arteritis: a cross-sectional screening of fifty-four prospectively followed patients. Arthritis Rheum2008; 59: 422–30.
8.
Prieto-GonzálezSArguisPGarcía-MartínezAet al. Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography. Ann Rheum Dis2012; 71: 1170–6.
9.
GhinoiAPipitoneNNicoliniAet al. Large-vessel involvement in recent-onset giant cell arteritis: a case-control colour-Doppler sonography study. Rheumatology (Oxford) 2012; 51: 730–4.
10.
KermaniTAWarringtonKJCrowsonCSet al. Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis. Ann Rheum Dis2013; 72: 1989–94.
11.
KebedDTBoisJPConnollyHMet al. Spectrum of aortic disease in the giant cell arteritis population. Am J Cardiol2018; 121: 501-8
12.
de BoyssonHDaumasAVautierMet al. Large-vessel involvement and aortic dilation in giant-cell arteritis. a multicenter study of 549 patients. Autoimmun Rev2018; 17: 391–8.
13.
BerthodPEAho-GléléSOrnettiPet al. CT analysis of the aorta in giant-cell arteritis: a case-control study. Eur Radiol2018; 28: 3676–84.
14.
KermaniTAWarringtonKJCrowsonCSet al. Predictors of dissection in aortic aneurysms from giant cell arteritis. J Clin Rheumatol2016; 22: 184–7.
DejacoCRamiroSDuftnerCet al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis2018; 77: 636–43.
17.
HellmichBAguedaAMontiSet al. 2018 update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis2020; 79: 19–30.
18.
HughesGCAndersenNDMcCannRL.Management of acute type B aortic dissection. J Thorac Cardiovasc Surg2013; 145: S202–7.
19.
DrososGCVedderDHoubenEet al. EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome. Ann Rheum Dis. 2022; 81: 768–79.
